COPD Clinical Trials in Nagoya
3 recruitingNagoya, Japan
Showing 1–3 of 3 trials
Recruiting
Phase 3
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
Chronic Obstructive Pulmonary Disease (COPD)
AstraZeneca990 enrolled266 locationsNCT06878261
Recruiting
Phase 3
A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary Disease
Chronic Obstructive Pulmonary Disease (COPD)
Hoffmann-La Roche1,290 enrolled462 locationsNCT05595642
Recruiting
Zephyr Valve Japan Post-Marketing Surveillance
COPDEmphysemaSevere Emphysema
Pulmonx Corporation140 enrolled17 locationsNCT06332885